NMG
IMGN

New Millennium Group’s Immunogen Inc IMGN Stock Holding History

New Millennium Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-60
Closed -$1.78K – 432
2023
Q4 		$1.78K Hold
60
– – ﹤0.01% 333
2023
Q3 		$952 Hold
60
– – ﹤0.01% 329
2023
Q2 		$1.13K Hold
60
– – ﹤0.01% 334
2023
Q1 		$230 Hold
60
– – ﹤0.01% 406
2022
Q4 		$298 Hold
60
– – ﹤0.01% 440
2022
Q3 		$0 Sell
60
-10
-14% -$53 ﹤0.01% 420
2022
Q2 		$0 Buy
+70
New +$304 ﹤0.01% 400

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

New Millennium Group's IMGN Position: Q1 2024 in Review

New Millennium Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 60 shares — an estimated $1.78K sold.

New Millennium Group first reported a position in IMGN in Q2 2022 and held it in 7 quarters. The position peaked at $1.78K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • New Millennium Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • New Millennium Group sold 60 Immunogen Inc shares in Q1 2024, an estimated $1.78K.
  • New Millennium Group first reported a position in Immunogen Inc in Q2 2022 and held it in 7 quarters.
  • New Millennium Group's Immunogen Inc position peaked at $1.78K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on New Millennium Group's 13F filing for Q1 2024, filed 15 May 2024.